Building a Risk-Based Data Integrity Program
Can your team reconstruct the decisions behind every critical record? Reliable data is essential to product quality, but gaps in access controls, audit trails, and record review can be difficult to spot until an inspection or investigation.
This whitepaper offers a practical framework for strengthening data integrity in drug and biologic manufacturing and testing. Learn how to identify high-risk records, build effective controls into daily work, and use a 90-day plan to begin improving your program.
Download the whitepaper to assess where your data integrity efforts should start.
Download EMMA International Whitepapers
Complete the form below to receive selected EMMA International whitepapers directly to your inbox.
